Reynolds Charles F, Lenze Eric, Mulsant Benoit H
University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Department of Psychiatry, Washington University School of Medicine, St Louis, MO, United States.
Handb Clin Neurol. 2019;167:429-435. doi: 10.1016/B978-0-12-804766-8.00023-6.
Late life depression is a significant public health problem as well as a burden on patients, their families, and caregivers. There are significant associations of late life depression with medical disorders and cognitive impairment, the latter due to effects of the depression itself or association with dementia. Diagnostic criteria and screening tests have continued to evolve and provide structure and guidelines for assessment. Accurate diagnosis and treatment are of utmost importance to improve quality of life, alleviate suffering, and prevent suicide. A number of effective antidepressant medications are available; combination therapy with these medications and cognitive behavioral therapy appear most efficacious, and maintenance therapy can decrease the chances of remission. A sequence for treatment of late life depression is provided, with strategies for treatment-resistant depression. The relationship of dementia to depression and the interaction of depression with mechanisms of aging are major foci of research.
晚年抑郁症是一个重大的公共卫生问题,也是患者及其家庭和护理人员的负担。晚年抑郁症与医学疾病和认知障碍之间存在显著关联,后者是由于抑郁症本身的影响或与痴呆症相关。诊断标准和筛查测试不断发展,为评估提供了框架和指导方针。准确的诊断和治疗对于提高生活质量、减轻痛苦和预防自杀至关重要。有多种有效的抗抑郁药物可供使用;这些药物与认知行为疗法的联合治疗似乎最为有效,维持治疗可以降低缓解的几率。本文提供了晚年抑郁症的治疗顺序以及难治性抑郁症的治疗策略。痴呆症与抑郁症的关系以及抑郁症与衰老机制的相互作用是主要的研究重点。